| 摘要 |
The present invention pertains to an antitumor agent including β-cyclodextrin and derivatives thereof. The present invention also pertains to β-cyclodextrin characterized by being used in combination with another antitumor agent, an antitumor agent including the same, combination therapy by β-cyclodextrin and another antitumor agent in the treatment of cancer, and the like. |
